Added to YB: 2025-07-22
Pitch date: 2025-07-20
DERM [bullish]
Journey Medical Corporation
+6.09%
current return
Author Info
The 10x Radar shares high-conviction small and microcap stock pitches with the potential to deliver multi-bagger returns. Sign up for the newsletter.
Company Info
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
Market Cap
$201.1M
Pitch Price
$7.23
Price Target
N/A
Dividend
N/A
EV/EBITDA
-165.92
P/E
-19.72
EV/Sales
3.39
Sector
Pharmaceuticals
Category
growth
Management Talks: Journey Medical — A Classic Execution Story in the Making
DERM: Emrosi (oral rosacea med) launched April 2025 already hitting 1,000 weekly scripts ($20M+ run rate). Break-even base biz ($55M+ annual) means Emrosi drops to bottom line. 65% commercial coverage secured. $200M+ peak sales target. 64% gross margins improving. $21M cash, FCF+ in 2025. Ex-Medicis team led by CEO owning 10%, built this before.
Read full article (5 min)